Clinical Trials Browser

Observational × Hematologic Tests × Plasma cell × Clear all

NCT04827563 2026-03-04

Dyspnea and Cardiotoxicity in Multiple Myeloma Patients Who Receive Carfilzomib

OtherPlasma cell

Dyspnea, Multiple Myeloma, Cardiotoxicity